GUANZE MEDICAL released its interim results, with a profit attributable to shareholders of HKD 3.368 million, turning a profit compared to the same period last year
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, GUANZE MEDICAL announced its performance for the six months ending June 30, 2025. The group achieved revenue of RMB 31.855 million during the period, a year-on-year decrease of 20.42%; the profit attributable to the company's owners was RMB 3.368 million, turning from a loss to a profit year-on-year; basic earnings per share were RMB 0.003
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments